BPG is committed to discovery and dissemination of knowledge
Case Control Study
©Author(s) (or their employer(s)) 2026.
World J Gastroenterol. Mar 14, 2026; 32(10): 116128
Published online Mar 14, 2026. doi: 10.3748/wjg.v32.i10.116128
Table 1 Laboratory data from patients with celiac disease, siblings of celiac disease patients, and healthy subjects (control group), median (Q1-Q3)
Variable
CeD, n = 14
Siblings of CeD, n = 16
Control group, n = 19
P value1
P value1,2
P value1,3
P value1,4
BMI (kg/m2)15.28 (14.17-16.62)16.81 (4.62-18.12)19.51 (5.29-21.61)0.026a0.350.021a0.8
Glycemia (mmol/L)4.5 (4.43-4.78)4.45 (4.32-4.68)4.4 (4.25-4.7)0.936
Total cholesterol (mmol/L)3.95 (3.69-4.4)4.42 (3.83-4.79)3.83 (3.67-4.21)0.005a0.240.650.004a
HDL (mmol/L)1.35 (1.24-1.56)1.48 (1.32-1.7)1.26 (1.1-1.42)0.018a0.70.410.014a
LDL (mmol/L)2.47 (2.0-2.54)2.72 (2.22-2.97)2.36 (1.92-2.55)0.019a0.1210.017a
TGs (mmol/L)0.67 (0.58-0.88)0.8 (0.72-0.96)0.71 (0.66-0.8)0.548
ALT (U/L)24.0 (19.0-25.12)23.5 (16.0-26.8)15.0 (13.75-27.5)0.83
Fe (μmol/L)12.9 (10.4-19.7)17.8 (13.1-21.05)16.35 (14.4-21.25)0.34
Creatinine (μmol/L)34.45 (30.72-36.95)35.4 (30.55-44.92)51.55 (38.92-55.6)0.003a10.013a0.011a
Anti-tTG (U/mL)173.9 (77.7-200.0)2.0 (2.0-2.03)1.9 (1.9-1.9)< 0.001a< 0.001a< 0.001a< 0.001a


Write to the Help Desk